Company news
Ludwig Enterprises, Inc. (OTC:LUDG) news
Ludwig Enterprises, Inc. news releases on 6ix. Latest, May 29, 2025: Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive…
Press releases & updates
Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
May 29, 2025
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
May 7, 2025
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
April 29, 2025
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
April 22, 2025
Ludwig Enterprises Begins PCR Validation Test Process
November 6, 2024
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
October 23, 2024
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
September 23, 2024
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
September 23, 2024
Ludwig Announces Acquisition of Intellectual Property and Patent
September 16, 2024
Nova Mentis Assigns Intellectual Property
August 26, 2024
Ludwig Announces Substantial Corporate Initiatives
August 13, 2024
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
July 8, 2024
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
March 26, 2024
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
March 18, 2024
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
March 5, 2024
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched
January 30, 2024
Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program
January 8, 2024
Ludwig Enterprises Appoints Scott Silverman as CFO
November 15, 2023
Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company
November 13, 2023
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer
September 18, 2023
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
May 8, 2023
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
May 2, 2023
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
April 24, 2023
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
April 11, 2023
Decoding mRNA for Early Disease Detection, Treatment & Prevention
March 28, 2023
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
March 22, 2023
Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange
March 20, 2023
Ludwig Enterprises Developing New Partnerships to Fuel Growth
March 15, 2023
Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
March 13, 2023
Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical
March 8, 2023
Ludwig Enterprises Develops Program to Support Ketamine Clinics
March 6, 2023
New Scientific Evidence Suggests How Chronic Illnesses May Be Prevented
February 21, 2023
Ludwig Enterprises Launches Growth Plan
February 13, 2023
Ludwig Enterprises, Inc. (OTC: LUDG) Prepares to Trade on the OTCQB Market
January 11, 2023
Ludwig Enterprises Receives IRB Approval on Bladder Cancer Study
January 2, 2023
Ludwig Enterprises Releases Annual 2022 Shareholder Letter
December 20, 2022
Ludwig Enterprises Acquires Cutting-Edge Dietary Supplement Formula
December 5, 2022
Ludwig Enterprises Announces Progress Towards Planned IPO (S1 Filing)
November 16, 2022
Precision Genomics (a Ludwig Company) Revealed Major Medical News at a Sequire Spotlight Interview
November 15, 2022
Precision Genomics Successfully Attends the LD Micro Conference
November 6, 2022
Precision Genomics’ New mRNA Technology May Be a Solution to Help Diagnose and Establish Treatment for Long Covid
October 24, 2022
Ludwig’s Genomic-Based mRNA Inflammatory Index - A Ground-Breaking Technology
September 27, 2022
Ludwig Files a Patent That Could Be a Major Technology Breakthrough in Healthcare
September 21, 2022
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study
September 19, 2022
Ludwig Appoints Dr. Kyle Ambert Ph.D. to Scientific Advisory Board
July 20, 2022
Ludwig Announces Engagement of Marvin S. Hausman MD as Chief Science Consultant
July 18, 2022
Ludwig Enterprises Hires Anne Blackstone, CRNA as CEO and Director
July 11, 2022
Ludwig Enterprises, Inc. Note Holders Waive Interest to Strengthen Company's Financial Position - The Company Continues A New Pathway Forward
July 6, 2022
Ludwig Enterprises Sucessful 1st Round Funding -- New CEO -- New Division
July 4, 2022
Ludwig Enterprises, Inc. to Issue 8,047,167 New Common Shares at $0.01 per Share
March 14, 2021